Paresh Vyas

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 38

Top Topics

Acute Myeloid Leukemia

Dna Methylation

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Jurjen Versluis, Marlen Metzner, Ariel Wang, Patrycja Gradowska, Abin Thomas, Niels Asger Jakobsen, Alison Kennedy, Rachel Moore, Emma Boertjes, Christian M Vonk, Francois G Kavelaars, Melissa Rijken, Amanda Gilkes, Claire Schwab, H Berna Beverloo, Markus Gabriel Manz, Otto Visser, Catharina H M J Van Elssen, Okke de Weerdt, Lidwine W Tick, Bart J Biemond, Marie-Christiane Vekemans, Sylvie D Freeman, Christine J Harrison, Jonathan Alistair Cook, Mike Dennis, Stephen Knapper, Ian Thomas, Charles F Craddock, Gert J Ossenkoppele, Bob Löwenberg, Nigel H Russell, Peter J M Valk, Paresh Vyas
Risk Stratification in Older Intensively Treated Patients With AML. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Merve Aksöz, Grigore-Aristide Gafencu, Bilyana Stoilova, Mario Buono, Ying Zhang, Sven Turkalj, Yiran Meng, Niels Asger Jakobsen, Marlen Metzner, Sally-Ann Clark, Ryan Beveridge, Supat Thongjuea, Paresh Vyas, Claus Nerlov
Hematopoietic stem cell heterogeneity and age-associated platelet bias are evolutionarily conserved. Science immunology 9 (98) (2024)
Elizabeth R Feldman, Yunqi Li, David J Cutler, Tracie C Rosser, Stephanie B Wechsler, Lauren Sanclemente, Angela L Rachubinski, Natalina Elliott, Paresh Vyas, Irene Roberts, Karen R Rabin, Michael Wagner, Bruce D Gelb, Joaquín Maximiliano Espinosa, Philip J Lupo, Adam J de Smith, Stephanie L Sherman, Elizabeth J Leslie
Genome-wide association studies of Down syndrome associated congenital heart defects. medRxiv : the preprint server for health sciences (2024)
Sylvie D Freeman, Abin Thomas, Ian Thomas, Robert K Hills, Paresh Vyas, Amanda Frances Gilkes, Marlen Metzner, Niels Asger Jakobsen, Alison Kennedy, Amy Rachel Moore, Nuria Marquez-Almuina, Sarah Burns, Sophie King, Georgia Andrew, Kathleen M E Gallagher, Rob S Sellar, Paul A Cahalin, Duruta Weber, Mike Dennis, Priyanka Mehta, Stephen Knapper, Nigel H Russell
Fractionated Versus Single Dose Gemtuzumab Ozogamicin with Determinants of Benefit in Older AML: UK NCRI AML18 Trial. Blood (2023)
Curtis A Lachowiez, Sanam Loghavi, Zhihong Zeng, Tomoyuki Tanaka, Yi June Kim, Hidetaka Uryu, Sven Turkalj, Niels Asger Jakobsen, Marlise R Luskin, Dzifa Yawa Duose, Rebecca S Slack Tidwell, Nicholas James Short, Gautam Borthakur, Tapan Mahendra Kadia, Lucia Masarova, George D Tippett, Prithviraj Bose, Elias J Jabbour, Farhad Ravandi, Naval G Daver, Guillermo Garcia Manero, Hagop M Kantarjian, Jacqueline S Garcia, Paresh Vyas, Koichi Takahashi, Marina Y Konopleva, Courtney D D DiNardo
A phase Ib/II study of ivosidenib with venetoclax +/- azacitidine in IDH1-mutated myeloid malignancies. Blood cancer discovery (2023)
Naval G Daver, Paresh Vyas, Suman Kambhampati, Monzr M Al Malki, Richard A Larson, Adam S Asch, Gabriel Mannis, Wanxing Chai-Ho, Tiffany N Tanaka, Terrence J Bradley, Deepa Jeyakumar, Eunice S Wang, Kendra Sweet, Hagop M Kantarjian, Guillermo Garcia Manero, Rami S Komrokji, Guan Xing, Giridharan Ramsingh, Camille Renard, Joshua F Zeidner, David A Sallman
Tolerability and Efficacy of the Anticluster of Differentiation 47 Antibody Magrolimab Combined With Azacitidine in Patients With Previously Untreated AML: Phase Ib Results. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
David A Sallman, Monzr M Al Malki, Adam S Asch, Eunice S Wang, Joseph G Jurcic, Terrence J Bradley, Ian W Flinn, Daniel A Pollyea, Suman Kambhampati, Tiffany N Tanaka, Joshua F Zeidner, Guillermo Garcia Manero, Deepa Jeyakumar, Rami S Komrokji, Jeffrey Lancet, Hagop M Kantarjian, Lin Gu, Yajia Zhang, Anderson Tan, Mark Chao, Carol O'Hear, Giridharan Ramsingh, Indu Lal, Paresh Vyas, Naval G Daver
Magrolimab in Combination With Azacitidine in Patients With Higher-Risk Myelodysplastic Syndromes: Final Results of a Phase Ib Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
David A Sallman, Monzr M Al Malki, Adam S Asch, Eunice S Wang, Joseph G Jurcic, Terrence J Bradley, Ian W Flinn, Daniel A Pollyea, Suman Kambhampati, Tiffany N Tanaka, Joshua F Zeidner, Guillermo Garcia Manero, Deepa Jeyakumar, Rami S Komrokji, Jeffrey Lancet, Hagop M Kantarjian, Lin Gu, Yajia Zhang, Anderson Tan, Mark Chao, Carol O'Hear, Giridharan Ramsingh, Indu Lal, Paresh Vyas, Naval G Daver
Magrolimab in Combination With Azacitidine in Patients With Higher-Risk Myelodysplastic Syndromes: Final Results of a Phase Ib Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Paresh Vyas
Changing treatment changing prognosis of mutations. Blood 142 (19) (2023)
Sarah Gooding, Naser Ansari-Pour, Mohammad Kazeroun, Kubra Karagoz, Ann Polonskaia, Mirian Salazar, Evie Fitzsimons, Korsuk Sirinukunwattana, Selina Chavda, Maria Ortiz Estevez, Fadi Towfic, Erin Flynt, William Pierceall, Daniel Royston, Kwee L Yong, Karthik Ramasamy, Paresh Vyas, Anjan Thakurta
Loss of COP9 signalosome genes at 2q37 is associated with IMiD resistance in multiple myeloma. Blood 140 (16) (2022)
Naval G Daver, Abhishek Maiti, Tapan Mahendra Kadia, Paresh Vyas, Ravindra Majeti, Andrew H Wei, Guillermo Garcia Manero, Charles F Craddock, David A Sallman, Hagop M Kantarjian
TP53-Mutated Myelodysplastic Syndrome and Acute Myeloid Leukemia: Biology, Current Therapy, and Future Directions. Cancer discovery 12 (11) (2022)
Daniel A Arber, Attilio Orazi, Robert P Hasserjian, Michael J Borowitz, Katherine R Calvo, Hans Michael Kvasnicka, Sa A Wang, Adam Bagg, Tiziano Barbui, Susan Branford, Carlos E Bueso-Ramos, Jorge E Cortes, Paola Dal Cin, Courtney D D DiNardo, Hervé Dombret, Eric J Duncavage, Benjamin L Ebert, Elihu H Estey, Fabio Facchetti, Kathryn Foucar, Naseema Gangat, Umberto Gianelli, Lucy A Godley, Nicola Gökbuget, Jason Gotlib, Eva Hellström-Lindberg, Gabriela S Hobbs, Ronald Hoffman, Elias J Jabbour, Jean-Jacques Kiladjian, Richard A Larson, Michelle M Le Beau, Mignon L-C Loh, Bob Löwenberg, Elizabeth A Macintyre, Luca Malcovati, Charles G Mullighan, Charlotte M Niemeyer, Olatoyosi M Odenike, Seishi Ogawa, Alberto Orfao, Elli Papaemmanuil, Francesco Passamonti, Kimmo Porkka, Ching-Hon Pui, Jerald P Radich, Andreas Reiter, Maria Rozman, Martina Rudelius, Michael R Savona, Charles A Schiffer, Annette Schmitt-Graeff, Akiko Shimamura, Jorge Sierra, Wendy A Stock, Richard M Stone, Martin S Tallman, Jürgen Thiele, Hwei-Fang Tien, Alexandar Tzankov, Alessandro Maria Maria Vannucchi, Paresh Vyas, Andrew H Wei, Olga K Weinberg, Agnieszka Świątek, Mario Cazzola, Hartmut Döhner, Ayalew Tefferi
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data. Blood 140 (11) (2022)
Alexander E Perl, Paresh Vyas
Shall We Dance: Evolving Partnerships of Targeted Therapies for AML. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (13) (2022)
Stéphane de Botton, Pau Montesinos, Andre Schuh, Cristina Papayannidis, Paresh Vyas, Andrew H Wei, Hans Beier Ommen, Sergey Semochkin, Hee-Je Kim, Richard A Larson, Jamie Koprivnikar, Olga Frankfurt, Felicitas R Thol, Jörg Chromik, Jenny L Byrne, Arnaud Pigneux, Xavier Thomas, Olga Salamero, María-Belén Vidriales, Vadim A Doronin, Hartmut Döhner, Amir T Fathi, Eric Laille, Xin Yu, Maroof Hasan, Patricia Martín-Regueira, Courtney D D DiNardo
Enasidenib vs conventional care in mutant-IDH2 relapsed/refractory acute myeloidleukemia: a randomized, phase 3 trial. Blood (2022)
Guillermo Garcia Manero, Valeria Santini, Antonio Almeida, Uwe Platzbecker, Anna Jonasova, Lewis R Silverman, Jose Falantes, Gianluigi Reda, Francesco Buccisano, Pierre Fenaux, Rena Buckstein, Maria Diez Campelo, Stephen Larsen, David Valcarcel, Paresh Vyas, Valentina Giai, Esther Natalie Oliva, Jake Shortt, Dietger Niederwieser, Moshe Mittelman, Luana Fianchi, Ignazia La Torre, Jianhua Zhong, Eric Laille, Daniel Lopes de Menezes, Barry Skikne, C L Beach, Aristoteles Giagounidis
Phase III, Randomized, Placebo-Controlled Trial of CC-486 (Oral Azacitidine) in Patients With Lower-Risk Myelodysplastic Syndromes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (13) (2021)
Paresh Vyas
Poorer Clinical Outcomes for Black Patients with AML: A Wake-Up Call for Better Data and Greater Understanding of Cancer Outcomes in All Ethnic Groups. Cancer discovery 11 (3) (2021)
Ivo S Muskens, Shaobo Li, Thomas Jackson, Natalina Elliot, Helen M Hansen, Swe Swe Myint, Priyatama Pandey, Jeremy M Schraw, Ritu Roy, Joaquin Anguiano, Katerina Goudevenou, Kimberly D Siegmund, Philip J Lupo, Marella F T R de Bruijn, Kyle M Walsh, Paresh Vyas, Xiaomei Ma, Anindita Roy, Irene Roberts, Joseph L Wiemels, Adam J de Smith
The genome-wide impact of trisomy 21 on DNA methylation and its implications for hematopoiesis. Nature communications 12 (1) (2021)
Courtney D D DiNardo, Anthony S Stein, Eytan M Stein, Amir T Fathi, Olga Frankfurt, Andre C Schuh, Hartmut Döhner, Giovanni Martinelli, Prapti A Patel, Emmanuel Raffoux, Peter Tan, Amer M Zeidan, Stéphane de Botton, Hagop M Kantarjian, Richard M Stone, Mark G Frattini, Frederik Lersch, Jing Gong, Diego A Gianolio, Vickie Zhang, Aleksandra Franovic, Bin Fan, Meredith Goldwasser, Scott Daigle, Sung Choe, Bin Wu, Thomas Winkler, Paresh Vyas
Mutant Isocitrate Dehydrogenase 1 Inhibitor Ivosidenib in Combination With Azacitidine for Newly Diagnosed Acute Myeloid Leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (1) (2020)
Shalini Singh, Doaa Ahmed, Hamid Dolatshad, Dharamveer Tatwavedi, Ulrike Schulze, Andrea Sanchi, Sarah Ryley, Ashish Dhir, Lee Carpenter, Suzanne M Watt, David J Roberts, Amal M Abdel-Aal, Sohair K Sayed, Somaia A Mohamed, Anna Schuh, Paresh Vyas, Sally Killick, Andriana G Kotini, Eirini P Papapetrou, Daniel H Wiseman, Andrea Pellagatti, Jacqueline Boultwood
SF3B1 mutations induce R-loop accumulation and DNA damage in MDS and leukemia cells with therapeutic implications. Leukemia 34 (9) (2020)
Laura Godfrey, Nicholas T Crump, Sorcha O'Byrne, I-Jun Lau, Siobhan Rice, Joe R Harman, Thomas Jackson, Natalina Elliott, Gemma Buck, Christopher Connor, Ross Thorne, David J H F Knapp, Olaf Heidenreich, Paresh Vyas, Pablo Menendez, Sarah Inglott, Philip Ancliff, Huimin Geng, Irene Roberts, Anindita Roy, Thomas A Milne
H3K79me2/3 controls enhancer-promoter interactions and activation of the pan-cancer stem cell marker PROM1/CD133 in MLL-AF4 leukemia cells. Leukemia 35 (1) (2020)
Naval G Daver, Andrew H Wei, Daniel A Pollyea, Amir T Fathi, Paresh Vyas, Courtney D D DiNardo
New directions for emerging therapies in acute myeloid leukemia: the next chapter. Blood cancer journal 10 (10) (2020)
David Cruz Hernandez, Paresh Vyas
Oncogenic Drivers and Development. Cancer discovery 9 (12) (2020)
Gert Ossenkoppele, Paresh Vyas
BCL-2 Inhibitor and Conventional Chemotherapy Combinations for Acute Myeloid Leukemia: Shifting From the Unfit to the Fit Patient With AML. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 38 (30) (2020)
Paresh Vyas
Disease Models & Mechanisms announces a new Editor-in-Chief. Disease models & mechanisms 13 (12) (2020)
Douglas Rafaele Almeida Silveira, Juan Luiz Coelho-Silva, Wellington F Silva, Grant Vallance, Diego Antonio Pereira-Martins, Maria I A Madeira, Lorena L Figueredo-Pontes, Elvira D R P Velloso, Belinda P Simões, Andy Peniket, Robert Danby, Eduardo Magalhaes Rego, Paresh Vyas, Fabiola Traina, Israel Bendit, Lynn Quek, Vanderson Geraldo Rocha
A multicenter comparative acute myeloid leukemia study: can we explain the differences in the outcomes in resource-constrained settings? Leukemia & lymphoma 62 (1) (2020)
Charles F Craddock, Aimee Jackson, Justin Loke, Shamyla Siddique, Andrea Hodgkinson, John Mason, Georgia Andrew, Sandeep Nagra, Ram Malladi, Andrew Peniket, Maria H Gilleece, Rahuman Salim, Eleni Tholouli, Victoria Potter, Charles Crawley, Keith Wheatley, Rachel Protheroe, Paresh Vyas, Ann Hunter, Anne Parker, Keith Wilson, Jiří Pavlů, Jennifer L Byrne, Richard Dilon, Naeem Khan, Sylvie D Freeman, Sylvie D Freeman
Augmented Reduced-Intensity Regimen Does Not Improve Postallogeneic Transplant Outcomes in Acute Myeloid Leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (7) (2020)
Damien Roosweil, Camille Decaudin, Marine Armand, Véronique Della-Valle, M'boyba K Diop, Hussein Ghamlouch, Virginie Ropars, Cécile Hérate, Diane Lara, Eric Durot, Rima Haddad, Elena Mylonas, Frederik Damm, Francoise Pflumio, Bilyana Stoilova, Marlen Metzner, Olivier Elemento, Philippe Dessen, Valérie Camara-Clayette, François-Loïc Cosset, Els Verhoeyen, Véronique Leblond, Vincent Ribrag, Pascale Cornillet-Lefebvre, Philippe Rameau, Nabih Azar, Frédéric Charlotte, Pierre Morel, Jean-Baptiste Charbonnier, Paresh Vyas, Thomas Mercher, Said Aoufouchi, Nathalie Droin, Christel Guillouf, Florence Nguyen-Khac, Olivier A Bernard
A Recurrent Activating Missense Mutation in Waldenström Macroglobulinemia Affects the DNA Binding of the ETS Transcription Factor SPI1 and Enhances Proliferation. Cancer discovery 9 (6) (2019)
Laura C Godfrey, Nicholas T Crump, Ross Thorne, I-Jun Lau, Emmanouela Repapi, Dimitra Dimou, Alastair L Smith, Joe R Harman, Jelena M Telenius, A Marieke Oudelaar, Damien J Downes, Paresh Vyas, Jim R Hughes, Thomas A Milne
DOT1L inhibition reveals a distinct subset of enhancers dependent on H3K79 methylation. Nature communications 10 (1) (2019)
Detlef Haase, Kristen E Stevenson, Donna S Neuberg, Jaroslaw P Maciejewski, Aziz Nazha, Mikkael A Sekeres, Benjamin L Ebert, Guillermo Garcia-Manero, Claudia Haferlach, Torsten Haferlach, Wolfgang Kern, Seishi Ogawa, Yasunobu Nagata, Kenichi Yoshida, Timothy A Graubert, Matthew J Walter, Alan F List, Rami S Komrokji, Eric Padron, David Sallman, Elli Papaemmanuil, Peter J Campbell, Michael R Savona, Adam Seegmiller, Lionel Adès, Pierre Fenaux, Lee-Yung Shih, David Bowen, Michael J Groves, Sudhir Tauro, Michaela Fontenay, Olivier Kosmider, Michal Bar-Natan, David Steensma, Richard Stone, Michael Heuser, Felicitas Thol, Mario Cazzola, Luca Malcovati, Aly Karsan, Christina Ganster, Eva Hellström-Lindberg, Jacqueline Boultwood, Andrea Pellagatti, Valeria Santini, Lynn Quek, Paresh Vyas, Heinz Tüchler, Peter L Greenberg, Rafael Bejar, null null
TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups. Leukemia 33 (7) (2019)
Sorcha O'Byrne, Natalina Elliott, Siobhan Rice, Gemma Buck, Nicholas Fordham, Catherine Garnett, Laura Godfrey, Nicholas T Crump, Gary Wright, Sarah Inglott, Peng Hua, Bethan Psaila, Benjamin Povinelli, David J H F Knapp, Antonio Agraz-Doblas, Clara Bueno, Ignacio Varela, Phillip Bennett, Hashem Koohy, Suzanne M Watt, Anastasios Karadimitris, Adam J Mead, Phillip Ancliff, Paresh Vyas, Pablo Menendez, Thomas A Milne, Irene Roberts, Anindita Roy
Discovery of a CD10-negative B-progenitor in human fetal life identifies unique ontogeny-related developmental programs. Blood 134 (13) (2019)
Hedia Chagraoui, Maiken S Kristiansen, Juan Pablo Ruiz, Ana Serra-Barros, Johanna Richter, Elisa Hall-Ponselé, Nicki Gray, Dominic Waithe, Kevin Clark, Philip Hublitz, Emmanouela Repapi, Georg W Otto, Paul Sopp, Stephen Taylor, Supat Thongjuea, Paresh Vyas, Catherine Porcher
SCL/TAL1 cooperates with Polycomb RYBP-PRC1 to suppress alternative lineages in blood-fated cells. Nature communications 9 (1) (2018)
Hartmut Döhner, Anna Dolnik, Lin Tang, John F Seymour, Mark D Minden, Richard M Stone, Teresa Bernal Del Castillo, Haifa Kathrin Al-Ali, Valeria Santini, Paresh Vyas, C L Beach, Kyle J MacBeth, Barry S Skikne, Steve Songer, Nora Tu, Lars Bullinger, Hervé Dombret
Cytogenetics and gene mutations influence survival in older patients with acute myeloid leukemia treated with azacitidine or conventional care. Leukemia 32 (12) (2018)
Lynn Quek, Muriel D David, Alison Kennedy, Marlen Metzner, Michael Amatangelo, Alan Shih, Bilyana Stoilova, Cyril Quivoron, Mael Heiblig, Christophe Willekens, Véronique Saada, Samar Alsafadi, M S Vijayabaskar, Andy Peniket, Oliver A Bernard, Sam Agresta, Katharine Yen, Kyle MacBeth, Eytan Stein, George S Vassiliou, Ross Levine, Stephane De Botton, Anjan Thakurta, Virginie Penard-Lacronique, Paresh Vyas
Clonal heterogeneity of acute myeloid leukemia treated with the IDH2 inhibitor enasidenib. Nature medicine 24 (8) (2018)
Dimitris Karamitros, Bilyana Stoilova, Zahra Aboukhalil, Fiona K Hamey, Andreas Reinisch, Marina Samitsch, Lynn Quek, Georg W Otto, Emmanouela Repapi, Jessica Doondeea, Batchimeg Usukhbayar, Julien Calvo, Stephen Taylor, Nicolas Goardon, Emmanuelle Six, Francoise Pflumio, Catherine Porcher, Ravindra Majeti, Berthold Göttgens, Paresh Vyas
Single-cell analysis reveals the continuum of human lympho-myeloid progenitor cells. Nature immunology 19 (1) (2017)
Alice Giustacchini, Supat Thongjuea, Nikolaos Barkas, Petter S Woll, Benjamin J Povinelli, Christopher A G Booth, Paul Sopp, Ruggiero Norfo, Alba Rodriguez-Meira, Neil Ashley, Lauren Jamieson, Paresh Vyas, Kristina Anderson, Åsa Segerstolpe, Hong Qian, Ulla Olsson-Strömberg, Satu Mustjoki, Rickard Sandberg, Sten Eirik W Jacobsen, Adam J Mead
Single-cell transcriptomics uncovers distinct molecular signatures of stem cells in chronic myeloid leukemia. Nature medicine 23 (6) (2017)
Sachith Mettananda, Chris A Fisher, Deborah Hay, Mohsin Badat, Lynn Quek, Kevin Clark, Philip Hublitz, Damien Downes, Jon Kerry, Matthew Gosden, Jelena Telenius, Jackie A Sloane-Stanley, Paula Faustino, Andreia Coelho, Jessica Doondeea, Batchimeg Usukhbayar, Paul Sopp, Jacqueline A Sharpe, Jim R Hughes, Paresh Vyas, Richard J Gibbons, Douglas R Higgs
Editing an α-globin enhancer in primary human hematopoietic stem cells as a treatment for β-thalassemia. Nature communications 8 (1) (2017)
Lynn Quek, Georg W Otto, Catherine Garnett, Ludovic Lhermitte, Dimitris Karamitros, Bilyana Stoilova, I-Jun Lau, Jessica Doondeea, Batchimeg Usukhbayar, Alison Kennedy, Marlen Metzner, Nicolas Goardon, Adam Ivey, Christopher Allen, Rosemary E Gale, Benjamin M Davies, Alexander Sternberg, Sally B Killick, Hannah Hunter, Paul Cahalin, Andrew Price, Andrew J Carr, Michael J Griffiths, Paul Virgo, Stephen Mackinnon, David Grimwade, Sylvie Freeman, Nigel Russell, Charles F Craddock, Adam Mead, Andrew Peniket, Catherine Porcher, Paresh Vyas
Genetically distinct leukemic stem cells in human CD34- acute myeloid leukemia are arrested at a hemopoietic precursor-like stage. The Journal of experimental medicine 213 (8) (2016)
Ross Kinstrie, Dimitris Karamitros, Nicolas Goardon, Heather Morrison, Mike Hamblin, Lisa Robinson, Richard E Clark, Mhairi Copland, Paresh Vyas
Heterogeneous leukemia stem cells in myeloid blast phase chronic myeloid leukemia. Blood advances 1 (3) (2016)
Paresh Vyas
Targeting HIF function: the debate continues. Blood 124 (24) (2015)